Proxidrugs in the fight against pathogenic proteins

Cells have an efficient waste disposal system. Proxidrugs utilize this system as part of new treatments for cancer, infections and Alzheimer’s disease. Scientists at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP are working with partners to develop this new drug class.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup